()
 
 

Overview

Xcorporeal, Inc. is a medical device company developing an innovative extra-corporeal platform technology that may be used in devices to replace the function of various human organs. The platform will lead to three initial products; a device for home hemodialysis, another device for hospital Renal Replacement Therapy (RRT) and the WAK for continuous ambulatory hemodialysis. These devices will seek to provide patients with improved, efficient and cost effective therapy. The RRT markets represent multibillion dollar opportunities.


Contact Information

11150 Santa Monica Boulevard
Suite 340
Los Angeles, CA 90025

tel: 310-424-5668
fax:
http://www.xcorporeal.com

,  



Investor Relations



tel:
fax:




Stock

Exchange: AMEX
Industry: Medical Appliances & Equipment
Market Cap: $29.4M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.